All News

Data from the long-term study of erenumab are very surprising in the sense that many of the patients continued to have significant results which continued for the duration of the study, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

One development in migraine science is the hypothesis that sex differences in migraine prevalence may be accounted for, in part, at the nociceptor level, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.

This week, the top managed care news included progress made in diabetes technology coverage and access among Medicare beneficiaries; an inside look into how colleges and universities addressed the COVID-19 pandemic; a recap of the Patient-Centered Oncology Care® 2020 virtual meeting.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo